文献速递先天性心脏病外科

异位综合征不是Fontan术后远期不良结局的危险因素

Heterotaxy Is Not a Risk Factor for Adverse Long-Term Outcomes After Fontan Completion.
PubMed 文献 · Ann Thorac Surg · 2019-12-28

该研究基于两国Fontan注册数据库(n=1540),比较异位综合征患者(n=109)与无综合征患者(n=1431)在Fontan完成出院后的远期结局。

要点

  • 异位综合征患者在Fontan完成后远期Fontan失败风险与无综合征患者无显著差异。
  • 异位综合征是Fontan术后心律失常的独立危险因素,需加强监测。
  • 右同工型与左同工型异位综合征的远期Fontan失败风险无差异。

核心结论

  • 异位综合征一旦成功完成Fontan手术,并非Fontan失败的重要危险因素。
  • 异位综合征患者Fontan术后心律失常风险显著高于无综合征患者。

研究设计与样本

  • 两国Fontan注册数据库分析,总样本n=1540,异位综合征组109例,无综合征组1431例。
  • 采用倾向性评分匹配后得到异位综合征73例与无综合征439例进行对比分析。

临床怎么用

  • 对异位综合征患者Fontan术后应加强心律失常监测与长期随访。
  • 异位综合征不应作为Fontan术后远期Fontan失败的独立预判因素。

局限性

  • 两组样本量差异大(109 vs 1431),倾向性评分匹配后异位综合征组仅73例。
  • 为注册数据库回顾性分析,可能存在未校正混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heterotaxy is considered a risk factor for poor outcomes after the Fontan operation. However, long-term data to support this notion are lacking. The aims of this study were to ascertain the long-term outcomes of patients with heterotaxy after hospital discharge after Fontan completion and to compare these outcomes with those of a contemporary nonheterotaxy cohort. METHODS: A binational Fontan registry (n = 1540) was analyzed to identify patients with heterotaxy and compare them with patients without heterotaxy. The primary composite end point was Fontan failure, encompassing death, heart transplantation, Fontan takedown or conversion, protein-losing enteropathy, plastic bronchitis, or New York Heart Association functional class III or IV. RESULTS: A total of 109 patients with heterotaxy were identified and they were compared with 1431 nonheterotaxy patients after Fontan completion. There was no difference in unadjusted 15-year freedom from Fontan failure (heterotaxy, 78% vs nonheterotaxy, 85%; P = .2). Patients in the heterotaxy group had a significantly higher cumulative incidence of post-Fontan arrhythmias (P < .001). Propensity-score matching for confounders yielded 73 patients with heterotaxy matched with 439 patients without heterotaxy, in whom 15-year freedom from Fontan failure was also not different (heterotaxy, 76% vs nonheterotaxy, 81%; P = .2). There was no difference in 15-year freedom from Fontan failure in patients with right vs left isomerism (right isomerism, 80% vs left isomerism, 76%; P = .7). CONCLUSIONS: Although heterotaxy may complicate the pre-Fontan course, once the Fontan procedure is successfully completed, heterotaxy does not appear to be an important risk factor for Fontan failure. Patients with heterotaxy are at a higher risk of post-Fontan arrhythmias compared with patients without heterotaxy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Marathe SP, Zannino D, Cao JY, et al. Heterotaxy Is Not a Risk Factor for Adverse Long-Term Outcomes After Fontan Completion. Ann Thorac Surg. 2019. PMID: 31891693. doi:10.1016/j.athoracsur.2019.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。